Biospective
Biospective specializes in preclinical neuroscience CRO services, focusing on rodent models of CNS diseases, and offers a range of advanced imaging, histopathology, and biomarker analysis services.
Specialized Research Services
Biospective specializes in preclinical neuroscience CRO services, focusing on rodent models of central nervous system (CNS) diseases. The services are tailored to various models of CNS diseases including Alzheimer's, Parkinson's, ALS, and Multiple Sclerosis. The company operates from its facility at 1255 Peel, Suite 560, Montréal, Québec H3B 2T9, Canada.
In Vivo Imaging Services
Biospective provides comprehensive in vivo imaging services leveraging advanced MRI, PET, and CT technologies. These services enable detailed and precise imaging of rodent models, which is critical for studying CNS diseases. The combination of these imaging modalities helps in understanding disease progression and therapeutic effects.
Histopathology Facility
Biospective operates a state-of-the-art histopathology facility dedicated to tissue analysis. This facility supports a broad range of histological techniques, including advanced staining and multiplex immunofluorescence, which are essential for detailed and quantitative tissue analysis in preclinical studies.
Advanced Image Processing Techniques
Biospective utilizes advanced image processing and analysis techniques for quantitative digital image analysis. These techniques ensure high accuracy and reproducibility in the interpretation of imaging data, which is crucial for the assessment of rodent models in CNS disease research.
Comprehensive Biomarker Analysis
Biospective offers fluid and cellular biomarker analysis, including blood and cerebrospinal fluid (CSF) biomarkers. The availability of these analyses supports a wide range of preclinical research needs, providing essential data for understanding disease mechanisms and evaluating the effectiveness of therapeutic interventions.